ORIC PHARMACEUTICALS INC's ticker is ORIC and the CUSIP is 68622P109. A total of 92 filers reported holding ORIC PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 6.67 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $52,103 | -48.3% | 8,612 | -33.7% | 0.00% | – |
| Q2 2023 | $100,756 | -47.5% | 12,984 | -63.9% | 0.00% | – |
| Q1 2022 | $192,000 | -66.0% | 35,968 | -6.4% | 0.00% | -100.0% |
| Q4 2021 | $565,000 | -25.9% | 38,428 | +5.4% | 0.00% | 0.0% |
| Q3 2021 | $762,000 | +5.8% | 36,443 | -10.4% | 0.00% | 0.0% |
| Q2 2021 | $720,000 | -13.8% | 40,685 | +19.3% | 0.00% | 0.0% |
| Q1 2021 | $835,000 | -26.5% | 34,089 | +1.6% | 0.00% | -50.0% |
| Q4 2020 | $1,136,000 | +246.3% | 33,559 | +155.6% | 0.00% | +100.0% |
| Q3 2020 | $328,000 | -26.0% | 13,129 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $443,000 | – | 13,129 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 602,272 | $2,698,000 | 8.92% |
| Column Group LLC | 3,568,181 | $15,985,000 | 3.40% |
| Euclidean Capital LLC | 747,550 | $3,349,000 | 2.85% |
| Invus Financial Advisors, LLC | 1,007,575 | $4,514,000 | 2.72% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,082,304 | $4,849,000 | 1.49% |
| Monaco Asset Management SAM | 364,741 | $1,634,000 | 0.71% |
| EcoR1 Capital, LLC | 3,418,068 | $15,313,000 | 0.53% |
| DAFNA Capital Management LLC | 415,926 | $1,863,000 | 0.51% |
| Boxer Capital, LLC | 1,054,000 | $4,722,000 | 0.30% |
| Casdin Capital, LLC | 601,515 | $2,695,000 | 0.23% |